Current Status of Conversion Hepatectomy After Sorafenib and Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma. Komatsu S, Yano Y, Mimura T, Minami A, et al. Anticancer Res 2024;44:3097-3103.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Komatsu S, Yano Y, Mimura T, Minami A, et al. Current Status of Conversion Hepatectomy After Sorafenib and Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma. Anticancer Res 2024;44:3097-3103.
PMID: 38925835